[ON EXTENDING THE INDICATIONS FOR A CENTRALLY ACTING ANTITUSSIVE (1-P-CHLOROPHENYL-2,3-DIMETHYL-4-DIMETHYLAMINO-2-BUTANOL HYDROCHLORIDE].
D020001:1-Butanol; D000605:Amino Alcohols; D000996:Antitussive Agents; D000440:Butanols; D003371:Cough; D004358:Drug Therapy; D006801:Humans; D016219:Immunotherapy, Adoptive; D009482:Neurophysiology
D000605:Amino Alcohols; D000996:Antitussive Agents; D000440:Butanols; C043958:2-butanol; C017135:clobutinol; D020001:1-Butanol
ANTITUSSIVE AGENTS; COUGH; DRUG THERAPY; NEUROPHYSIOLOGY; SILOMAT
ZUR AUSWEITUNG DER INDIKATION FUER EIN ZENTRALWIRKENDES ANTITUSSIVUM (1-P-CHLORPHENYL-2,3-DIMETHYL-4-DIMETHYLAMINO-BUTANOL-(2)-HYDROCHLORID)